SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-07-000903
Filing Date
2007-02-15
Accepted
2007-02-15 16:33:51
Documents
4
Period of Report
2007-02-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ARIAD PHARMACEUTICALS, INC. b64196ape8vk.htm 8-K 30636
2 EX-10.1 COMMON STOCK PURCHASE AGREEMENT b64196apexv10w1.txt EX-10.1 178273
3 EX-99.1 PRESS RELEASE DATED FEBRUARY 15, 2007 b64196apexv99w1.htm EX-99.1 28163
4 EX-99.2 PRESS RELEASE DATED FEBRUARY 15, 2007 b64196apexv99w2.htm EX-99.2 17498
  Complete submission text file 0000950135-07-000903.txt   256178
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21696 | Film No.: 07627907
SIC: 2836 Biological Products, (No Diagnostic Substances)